This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gordon M. Trenholme, MD; Paul E. Carson, MD

JAMA. 1978;240(21):2293-2295.

Abstract
Physicians should be prepared to provide prophylactic medications for travelers to malarious areas and to treat patients with malaria. Chloroquine hydrochloride is the suppressive agent of choice for treatment of mild infections due to all species of malaria except for those due to chloroquineresistant strains of Plasmodium falciparum. For treatment of severe infections with P falciparum and for treatment of all infections due to chloroquineresistant strains of P falciparum, quinine is the suppressive agent of choice. Chloroquine is also the prophylactic agent of choice for most travelers. To prevent infection with P vivax or P ovale, primaquine must also be given. A RBC glucose-6-phosphate dehydrogenase level should be obtained before administration of primaquine. For prophylaxis of chloroquine-resistant strains of P falciparum, no completely satisfactory regimen is presently available in the United States.

(JAMA 240:2293-2295, 1978)

Author Affiliations
From the Department of Pharmacology, Rush University, Chicago.

Footnotes
Reprint requests to Section of Infectious Disease, Department of Medicine, Rush-Presbyterian St Lukes Medical Center, 1753 W Harrison, Chicago, IL 60612 (Dr Trenholme).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hydroxychloroquine Treatment of Porphyria Cutanea Tarda
Malkinson and Levitt
Arch Dermatol 1980;116:1147-1150.
ABSTRACT